Mediterranean Diet for Post-menopausal Women: Effects on Bone Turnover

Completed · Not applicable

Conditions studied: Osteoporosis, Postmenopausal Bone Loss

In brief

The investigators propose a 24 week clinical research trial (12 week observational period followed by 12 week MedSD intervention) with feasibility of diet adoption and markers of bone turnover as the primary outcomes.

Key facts

Study ID

NCT01653275

Run by

UConn Health

People needed

22

Starts

2012-04-01

Expected to finish

2014-12-01

Last updated by the study team

2017-05-10

Who can join

Age: 65 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• postmenopausal women > 65 years
• BMI<30 kg/m2
• able to travel to clinical sites for follow-up visits
• willing to make no changes to habitual physical activity or calcium and vitamin D intake for the study duration

You may not qualify if…

• any disease that may affect bone metabolism, (i.e Paget's disease, primary hyperparathyroidism)
• cancers of any kind (except basal or squamous cell of skin) in past 5 years
• use of medication known to affect bone metabolism
• extreme dietary behaviors or supplementation in excess of DRI upper limits
• following a medically prescribed diet or dietary pattern similar to the MedSD
• history of chronic renal or liver disease
• history of hip fracture or known vertebral fracture within the past year
• persons with an allergy to fish or nuts.

Where it is running

• UCHC — Farmington, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.